$0.52-0.04 (-7.37%)
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.
NewGenIvf Group Limited in the Healthcare sector is trading at $0.52 with a market capitalization of $2M. Wall Street consensus targets $14.12 (1 analysts), implying a +2622.2% move over the next 12 months. The stock is currently near its 52-week low of $0.47, remaining 97.9% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|
| Total Revenue | $1.42Mβ | $1.28M | β | $1.27Mβ | $1.47M |
| Gross Profit | $524,025β | $118,017 | β | $539,135β | $648,827 |
| Operating Income | -$4.97Mβ | -$2.51M | β | -$1.09Mβ | $216,311 |
| Net Income | -$7.67Mβ | $16.82M | β | -$108,243β | -$19,857 |
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility ...